Abstract
Introduction
Candida albicans is generally a widespread fungal pathogen that is involved either in superficial or blood-disseminated infections (1, 2) . Oral Candida spp. is the most widely recognized contaminant found in the elderly or hospitalized patients, causing systemic or mucosal diseases (3) (4) (5) . The oral colonization with Candida spp. in the elderly is favored by prostheses wearing, poor oral/denture cleaning and low salivation stream (6) (7) (8) (9) .
The ability of C. albicans to form biofilms on both cellular and prosthetic device surfaces increases the severity of the infection. Biofilms are complex, three-dimensional microbial structures encased in an extracellular matrix that are connected to either a biotic or an abiotic surface (10) (11) (12) (13) (14) . Biofilms decrease the host immune system by an increased microbial resistance to antimicrobial agents (10, (13) (14) (15) and thus play a significant role in virulence. The C. albicans biofilms consist of yeast and hyphae, both of which being indispensable to fungal adherence and subsequent biofilm development (16) (17) (18) (19) . The increased prevalence of candidiasis worldwide has led to investigations of the possible correlations between adherence genes profiles and the adherence and biofilm development capacity, assessed phenotypically. Recently, the detection of a variety of regulators and effectors that included biofilm formation in C. albicans has increased the understanding of the complex mechanisms concerned with this process [reviewed in (20) ]. Various cell wall proteins, including Bcr1, a transcription factor that controls gene expression of cell wall proteins, have been revealed to play important roles in biofilm formation. In addition, Agglutinin-like sequences (ALS1, ALS3), and the hyphal wall protein 1 (HWP1) contribute to biofilm formation and maturation (21) (22) (23) . Also, a direct correlation between secreted aspartyl proteinase (SAP) production and C. albicans adherence capacity has been highlighted. It was observed that proteolytic C. albicans isolates exhibited a higher capacity of in vitro adherence to human oral epithelial cells compared with isolates that synthesized less proteinase (24) . In mice, an isolate that produced higher levels of proteinases also exhibited increased in vivo tissue colonization capacity of the liver, kidneys, and spleen, and led to the death of the mice (25) . The majority of the existing studies investigating the C. albicans biofilm production have focused on SAPs. In the anaerobic environments of the root canal systems and periodontal pockets, SAP secretion increases. This observation suggests that the virulence of C. albicans is significantly influenced by the concentration of oxygen in the infection site (26) . It has been demonstrated that pepstatin, an inhibitor of SAP2 (and probably of SAP1 and SAP3) decreased C. albicans biofilm development capacity with variable efficiency (27) . Pepstatin treatment decreased C. albicans adhesion and invasion of human epidermal cells and mucosa (28, 29, 30) . The EAP1 gene (extracellular adhesion protein) encodes a putative cell wall adhesin (31) that contains a signal peptide and a glycosylphosphatidylinositol anchor site; EAP1 gene is homologous to other yeast genes that code for cell wall proteins. Cell surface hydrophobicity (CSH) plays a vital role in C. albicans pathogenesis. Hydrophobic cells displayed higher adherence to both epithelial and endothelial cells and to extracellular matrix proteins, as well as greater resistance to phagocytosis (32). CSH varied due to different environmental conditions and growth phases (33) . The aim of the current study was to establish the adherence gene profiles of C. albicans isolates from respiratory tract secretions in patients hospitalized for cardiovascular diseases and to correlate them with the ability of the respective isolates to colonize the epithelial cells and to form biofilms on the inert substratum.
Materials and Methods

Fungal strains
In this study, we analyzed twenty-nine C. albicans strains isolated from patients admitted for cardiovascular surgery, aged 25-89 years and diagnosed with respiratory tract infections. Nineteen specimens were isolated from sputum and 10 samples from bronchial secretions. None of the patients was dental prosthesis wearer. The C. albicans ATCC10231 was used as reference strain.
Sabouraud Dextrose Agar (SDA) medium was used to initially isolate the strains, which, subsequently, were biochemically identified using the VITEK II automatic analyzer (bioMérieux), after inoculating Yeast plastic cards (YPC) with the required inoculum suspension. The YBC cards were then incubated at 37°C for 24-48 h and submitted for reading.
Biofilm microtiter assay
A microtiter plate method was used to assess the ability of C. albicans isolates to attach to an inert substratum and to examine the subsequent biofilm production. C. albicans isolates were maintained overnight in Sabouraud broth at 37°C and then centrifuged at 150 rpm. The cells were collected, washed by using phosphate buffered saline (PBS), and standardized to a density of 1 × 10 7 yeast cells/ml. A volume of100 µl of the yeast cells suspension was added to the wells of a 96-well plate and incubated at 37°C for 96 h. After incubation, the liquid content of the wells was discarded, and the wells were washed three times with distilled water in order to remove the non-adherent cells. Then, the cells adherent on the plastic wells were fixed with cold methanol for 5 min and then stained with crystal violet (CV) solution for 15 min (34, 35) . In order to evaluate the stained biofilms, first the wells were examined using an inverted microscope. Then, the biofilm formed on the plastic wells was resuspended with a 33% acetic acid solution and the optical density of the biofilm cell suspension was determined by measuring the absorbance of the colored suspension at 490 nm using an enzyme linked immunosorbent assay (ELISA) plate reader, the results being interpreted according to Melo et al. (36) . All tests were done in triplicate and biofilm production quantities were reported as the arithmetic mean of absorbance values of the three replicate test. The absorbance values of the negative controls (containing no cells) were subtracted from the values of the test wells to minimize background interference. The biofilm forming intensity was quantified according to their cut-offs by OD value as none absent (unable to form a biofilm), low (when< ~ ≤ 2x ODc), moderate (when< ~ ≤ 4x ODc) or high (> 4x ODc) (37) .
Evaluation of the capacity of adherence to HeLa cells
An adaptation of the Cravioto method was used to determine adherence capacity of each isolate to HeLa cells. The assay was performed as previously described (38) . HeLa cells were grown in 6-well plates for 24 h in Dulbecco's Modified Eagle's Medium (DMEM) involved with antibiotics; after this incubation, the cell monolayers reached 80% confluence. Wells were washed 3 times with PBS to remove the growth medium. To prepare the fungal suspension, yeast was grown in Sabouraud glucose broth supplemented with 3% glucose for 48 h at 37°C. Cells were centrifuged at 1500 rpm for 10 min, and the pellets were washed with PBS (pH ~7.2). The cell density in the final suspension was 10 7 colony forming units/ml (using a 0.5 McFarland standard). One ml of the final fungal suspension was added aseptically above each cellular monolayer. The plates were then incubated at 37°C for 2 h to allow the yeast cells to properly adhere to the cellular surface. Then, the cells were fixed with methanol for 5 min after washing with PBS three times. The wells were stained with a 1:10 Giemsa solution (Merck, Darmstadt, Germany) for 20 min, washed with tap water, used room temperature for drying, examined under microscope (2500 total magnification) with I.O., and then photographed with a Contax camera (supplied with Zeiss microscope). The adherence index (AIn) for each isolate was calculated as the percentage of Hela cell showing adherent fungal cells to the total number of HeLa cells. The average number of fungal cells adhered to one HeLa cell was also calculated.
Detection of adherence genes
The total DNA was isolated using the thermolysis method according to the protocol of Zang et al (39) . All purified strains were grown on SDA medium at 37°C for 24 h. Subsequently, isolated fungal colonies were routinely subcultured in Yeast Nitrogen Base (YNB; BD Diagnostics, Cowley, UK) medium enhanced with glucose (0.5% w/v) overnight at 37 °C, under stirring at 120 rev/min. Cells were harvested by centrifugation at 3000 g for 10 min at 4°C and the pellet was washed 2 times with 10 mL PBS (pH 7). The cellular density for each strain was adjusted to 1 x 10 7 cells/ml. Pooled biofilms from each collection site were carefully transferred to Eppendorf tubes that contained 1 mL of reduced transport fluid (RTF). Immediately after collection, the samples from each site were diluted and plated onto SDA medium with chloramphenicol (bioMérieux, Paris, France). The plates were incubated in a reduced oxygen atmosphere (10% CO 2 and 90% air) for 48 h at 37°C. DNA was extracted with slight modifications from a protocol by Nascimento et al. (40) . The yeast colonies were suspended in 1 mL of a solution containing 1 M sorbitol and 125 M ethylenediaminetetraacetic acid (EDTA). This suspension was centrifuged at 13000 g for 10 min at 25 °C. The pellet was resuspended in 0.5 mL lysis solution [1 M TrisHCl, pH 8.0, with 250 mM EDTA and 5% sodium dodecyl sulfate (SDS)] with 10 mL of proteinase K (Invitrogen), and incubated for 1 h at 65°C. Subsequently, 500 µl of 5 M potassium acetate was added to the mixture and incubated on ice for 2 h. The mixture was centrifuged at 13000 g for 10 min at 25 °C (40). The supernatant was transferred to an Eppendorf tube containing 1 mL absolute ethanol. The tubes were mixed by inversion centrifuged at 13000 g for 10 min at 4°C. The pellet was washed with 500 µl of ice cold 70% ethanol and then centrifuged at 13000 g for 10 min at 4°C. The final pellet was re-suspended in 0.5 mL of sterile MilliQ water. The DNA concentration was determined at 260 nm using a spectrophotometer (Genesys 10UV, Rochester, NY, USA). These data were used to prepare a standard with of 100 ng/ml concentration. The standard was stored for the next PCR reactions at 20°C. Simplex and multiplex PCR reactions using specific primers were used to identify C. albicans adhesion genes (41) 
was used to separate PCR products on 2% agarose gels using Tris-borate-EDTA running buffer (pH 8.0). The DNA, including the molecular mass ladder (1000 bp DNA ladder), was stained using a 0.5 µg/ml solution of ethidium bromide. The stained gel was visualized with UV illumination (Pharmacia LKB-MacroVue, San Gabriel, CA, USA).
Statistical analysis
Statistical analysis was carried out using SPSS version 16.0. For all statistical tests, P<0.05 was considered significant and P<0.01 highly significant. Inferential data analysis was performed to test. The contingency coefficients (C.C.) test was used to determine the correlation of the cause to association tables. The null hypothesis under Ho says that redistribution of the observed frequencies in the created association table through applying the new suggested method using stemleaf technique are randomly distributed (meaningless relationship) versus the alternative hypothesis which says that the contingency coefficient of the association table is meaningful. In addition, under and upper redistribution cutoff points were used to create 2 x 2 rank association tables and these were applied to the Steam-Leaf plotting technique.
Results
In this study, we analyzed 29 C. albicans isolates recently isolated from patients aged 25 to 89 years. The majority of the isolates (65%) were isolated from lower respiratory tract (bronchial) secretions. We observed no significant difference in isolation rates based on gender (male to female ratio was 1.08, P>0.05) ( Table 1) .
Most of the C. albicans isolates from the bronchial secretions exhibited a localized adherence pattern, while the vast majority of sputum strains exhibited an aggregative adherence pattern (Figure 1, Table 1 ). We observed that the isolated C. albicans strains adhered to HeLa cellular substratum with different intensities as revealed by the adherence index values (AIn) that ranged from 70 to 87.7% (Table 1) . Bronchial-derived strains had higher AIn compared to strains isolated from sputum ( Table 1 ). The majority of isolates from both bronchial and sputum samples developed biofilms on the inert Continued on page 6 Fig. 3 . Distribution of C. albicans adhesion genes in strains isolated from sputum and bronchial secretions substrate (Fig. 2) . Overall, isolates from the upper respiratory tract were higher biofilm producers, this feature being correlated with a high AIn (Fig. 2 insertion) . Previous research studies have shown that strains isolated from invasive infections tend to produce biofilms more intensely in comparison with isolates from non-invasive infections (42) . Our results indicated a generally non-statistically significant (P>0.05) correlation between the presence of ALS and SAP genes and AIn for C. albicans isolates that were isolated from sputum and bronchial secretions (Fig. 3, Table 1 ). There were, however, some exceptions. The ALS3gene presence in strains isolated from sputum and of SAP2 in those isolated from bronchial secretions were significantly correlated with a high AIn (P<0.05). However, the only significant associations between adherence genes and biofilm formation capacity were ALS1 in tracheal and ALS8 in sputum isolates (P<0.05). The ALS3 polymorphism led to variable biofilm production in different species isolated from sources such as blood, vulvo-vaginal secretions, and urine cultures (43) .
Discussion
Fungal infections due to C. albicans in critically ill hospitalized patients are a significant cause of morbidity and mortality worldwide. Peterson et al. (44) observed that 55% of hospitalized patients carried yeasts in their saliva. More specifically, Candida spp. strains were found in between 47-87% of in patients with advanced cancer, and in the oral mucosa of up to 80% of diabetic patients (40) . In our study, C. albicans strains that are isolated from patients hospitalized for cardiovascular surgery were predominantly from bronchial secretions (65 %). The ability to colonize host tissues is considered one of the most significant factors for C. albicans virulence (41) . Candida spp. adherence to human tissues permits the fungus to reach the minimum infective threshold and colonize a specific niche environment. Candida has a specific feature which enables it to survive and develop within different circumstances of healthy human body and then to invade tissues. Thus, the colonized area provides the essential ground for Candida development, proliferation, invasion, and dissemination (45) . However, any modification in the host immune system, or host environment, can lead to the switching C. albicans into a pathogenic form and then able of causing biofilm-associated infections were also noted to play a significant role in perpetuating these infections since these structures could allow the yeast to adhere to medical devices. However, there is limited information available as to the molecular mechanisms that mediate C. albicans adhesion to materials or mammalian cells. The relationship between the phenotype of a strain (e.g., the ability to adhere and/or form a biofilm) and genotype is also barely known. Our findings indicate that C. albicans isolated from bronchial secretions adhered better to cellular and inert substrata compared to sputum-isolated strains. These bronchial-derived strains also had a specific adherence gene profile. It has been previously described that ALS genes play an important role in C. albicans adherence and biofilm formation and growth, the ALS1 protein product being associated with the capacity of Candida spp. strains to adhere to endothelial cells and form biofilms (46) . We found that the presence of ALS3, ALS5, ALS6, and SAP9 genes is correlated with C. albicans adhesion to polystyrene and human epithelial cells. The SAP9 and ALS3 adherence genes contribute to the overall virulence of C. albicans strains, being usually expressed in virulent strains isolated from symptomatic infections and enable attachment to cellular and inert substrata. Our results differed compared with a previous study (47) in which the authors report-ed that other genes which were not identified in our study, respectively ALS1 and ALS9, were detected in the clinical isolates. In our study, 90% of the analyzed strains were SAP9 positive, the next most prevalent gene present in the strains being SAP5. We noticed that C. albicans isolates that expressed SAP9 were more virulent in comparison with isolates that expressed SAP5 and SAP6, and then the remaining analyzed genes, therefore SAP9 plays a significant role in biofilm development, probably through favoring yeast to hyphal transition, as a response to environmental stimuli via a cyclic adenosine monophosphate-(cAMP) dependent signaling pathway (48) . Hyphal development contributes to Candida invasion of epithelial cells and leads to host cell damage.
Conclusions
Our work describes the relationship between different phenotypic features that are related to cell adherence and biofilm development and the presence of adherence genes. The analyzed C. albicans strains were isolated from the respiratory tract of patients undergoing cardiovascular surgery. The isolates were able to adhere to cellular and inert substrata and to form biofilms. The investigation of the adherence gene profiles in our C. albicans isolate revealed the presence of several ALS genes, correlated with the respective isolates ability to colonize the cellular substratum. The isolates expressing theSAP9 were the most virulent, likely because SAP9 favors the yeast to hyphal transition. Overall, our study demonstrates that the PCR detection of adherence genes could represent a simple and cost effective tool for the prediction of the virulence capacity and pathogenic potential of different C albicans clinical isolates, replacing the more expensive and time-consuming phenotypic assays of adherence and biofilm development capacity.
